Judges Scientific plcLSE: JDG

Judges Scientific: Director/PDMR Shareholding

· Issued by Judges Scientific plc via RNS

Summary by 6ix AI

Judges Scientific, a group that acquires and develops scientific instrument companies, was told that 40 of its ordinary shares were bought on November 16, 2026 for Chief Financial Officer Brad Ormsby and his spouse under an automatic dividend reinvestment programme.

Key details

  • The 40 shares were bought in a single transaction at 3400.0p (pence) each.
  • The purchase took place on the London Stock Exchange, AIM Market (XLON).

6ix AI wrote this summary from the release below and checked it against the release.

Judges Scientific PLC
16 November 2026

16 November 2026

Judges Scientific plc

(“Judges Scientific” or the “Group”)

Director/PDMR Shareholding

Judges Scientific, a group focused on acquiring and developing companies in the scientific instrument sector, has been made aware of the following purchases of ordinary shares in the Group under an automatic dividend reinvestment programme on behalf of Brad Ormsby, Chief Financial Officer, full details of which are set out below:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bradley Ormsby and spouse

2

Reason for the notification

a)

Position/status

Chief Financial Officer and spouse

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Purchase of shares under a dividend reinvestment programme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

3400.0p

40

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

16/11/26

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

- Ends -

For further information please contact:

Judges Scientific plc

Tim Prestidge, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

Panmure Liberum (Joint Broker)

Edward Mansfield

William King

Tel : +44 (0) 20 3100 2222

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000

Alma (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Judges Scientific plc on 6ix

Earlier from Judges Scientific

All Judges Scientific news releases